Systemic Anti Cancer Therapy Protocols

These clinical protocols have been developed by local clinicians, with the support of the South West Clinical Network (SWCN). The information is provided as guidance only, and has no legal or official standing. The guidance does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and/or their guardian or carer. Availability of treatments may change, subject to NHS funding agreements. These protocols must be used in conjunction with local and national commissioning guidance.

The protocols are still being updated and more will be added to this website as they are completed. If you have any queries or suggestions, or would like to be involved in the development of these protocols please contact us

Nelarabine

Acute Lymphocytic Leukaemia

Haematology

Inotuzumab

Acute Lymphocytic Leukaemia

Haematology

Blinatumomab

Acute Lymphocytic Leukaemia

Haematology

Vyxeos

Acute Myeloid Leukaemia

Haematology

Midostaurin

Acute Myeloid Leukaemia

Haematology

Gemtuzumab Ozogamicin

Acute Myeloid Leukaemia

Haematology

FLAG/IDA

Acute Myeloid Leukaemia

Haematology

Clofarabine and Cytarabine

Acute Myeloid Leukaemia

Haematology

Azacitidine

Acute Myeloid Leukaemia

Haematology

ATRA

Acute Myeloid Leukaemia

Haematology

Arsenic trioxide

Acute Myeloid Leukaemia

Haematology

R-IDARAM

Lymphomas

Haematology

Search by filter

  • Haematology/Oncology

  • Location

  • Protocol Area